Tuesday, October 27, 2009
Sometimes it is better to wait on the sidelines... South Carolina did not participate in the collective suit by 32 states against Pfizer for its off-label marketing of the anti-psychotic drug, Zyprexa. If South Carolina has joined that suit, it would have received around $4.5 million. Instead, it brought its own lawsuit and now reports a $45 million settlement with Pfizer. The Post and Courier has more.
As of September 30th, Legal Newsline reportedthree additional Zyprexa cases remained pending: Mississippi before Judge Weinstein; Arkansas and Pennsylvania in state court.